Effect of high-frequency chest wall oscillation on the central and peripheral distribution of aerosolized diethylene triamine penta-acetic acid as compared to standard chest physiotherapy in cystic fibrosis

Chest

Volumn 129, Issue 3, 2006, Pages 712-717

  Stites, Steven W ^a,d   Perry, Gayln V ^a   Peddicord, Tom ^b   Cox, Glen ^a   McMillan, Chris ^a   Becker, Brian ^c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b FKA American Biosystems   (United States)

^c Hill Rom Inc   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

133Xe; Aerosol; Airway clearance; Central to peripheral deposition ratio; Chest physiotherapy; Cystic fibrosis; High frequency chest wall oscillation; Pulmonary

Indexed keywords

PENTETATE TECHNETIUM TC 99M; PENTETIC ACID; XENON 133;

ADULT; AEROSOL; AIRWAY OBSTRUCTION; ANALYTICAL PARAMETERS; ARTICLE; BREATHING EXERCISE; CENTRAL TO PERIPHERAL DEPOSITION RATIO; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DRUG DISTRIBUTION; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HIGH FREQUENCY CHEST WALL OSCILLATION; HIGH FREQUENCY OSCILLATION; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; MALE; MEDICAL INSTRUMENTATION; NEBULIZER; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL LUNG CAPACITY;

EID: 33645116246     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.3.712     Document Type: Article

References (26)

1. Stiller K, Geake T, Taylor J, et al. Acute lobar atelectasis: a comparison of two chest physiotherapy regimens. Chest 1990; 98:1336-1340
2. Thomas J, Cook DJ, Brooks D. Chest physical therapy management of patients with cystic fibrosis: a meta-analysis. Am J Respir Crit Care Med 1995; 151:846-850
3. Prasad SA, Main E. Finding evidence to support clearance techniques in cystic fibrosis. Disabil Rehabil 1998; 20:235-246
4. Tomkiewicz R, Biviji A, King M. Effects of oscillating air flow on the rheological properties and clearability of mucous gel simulants. Biorheology 1994; 31:511-520
5. Dasgupta B, Tomkiewicz R, Boyd W, et al. Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitro. Pediatr Pulmonol 1995; 20:78-82
6. King M, Phillips DM, Gross D, et al. Enhanced tracheal mucus clearance with high frequency chest wall compression. Am Rev Respir Dis 1983; 128:511-515
7. Chang HK, Weber M, King M. Mucus transport by high-frequency nonsymmetrical oscillatory airflow. J Appl Physiol 1988; 65:1203-1209
8. King M, Zidulka A, Phillips DM, et al. Tracheal mucus clearance in high-frequency oscillation: effect of peak flow bias. Eur Respir J 1990; 3:6-13
9. Arens R, Gozal D, Omlin KJ, et al. Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 1994; 150:1154-1157
10. Braggion C, Cappelletti LM, Zanolla L et al. Short-term effect of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study. Pediatr Pulmonol 1995; 19:16-22
11. Oermann CM, Sockrider MM, Giles D, et al. Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study. Pediatr Pulmonol 2001; 32:372-377
12. Varekojis SM, Douce FM, Flucke RL, et al. A comparison of therapeutic effectiveness of and preference for postural drainage and percussion, intrapulmonary percussive ventilation, and high-frequency chest wall compression in hospitalized cystic fibrosis patients. Respir Care 2003; 48:20-21
13. Harf A, Zidulka A, Chang HK. Nitrogen washout during tidal breathing with superimposed high-frequency chest wall oscillation. Am Rev Respir Dis 1985; 132:350-353
14. Smaldone GC, Messina MS. Flow limitations, cough and patterns of aerosol deposition in humans. J Appl Physiol 1985; 59:515-520
15. Chambers C, Klous D, Nantel N, et al. Does high-frequency chest compression (HFCC) during aerosol therapy affect lung deposition? Am J Respir Crit Care Med 1998; 157:A131
16. Portney LG, Watkins MP. Foundations of clinical research, applications for practice. 2nd ed. Upper Saddle River, NJ: Prentice Hall, 2000
17. Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis 1987; 136:1445-1449
18. LeConte P, Potel G, Peltier P, et al. Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis 1993; 147:1279-1282
19. O'Riordan TG, Iacono A, Keenan RJ, et al. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. Am J Respir Crit Care Med 1995; 151:516-521
20. Cabahug CJ, McPeek M, Palmer LB, et al. Utility of technetium-99m DTPA in determining regional ventilation. J Nucl Med 1996; 37:239-244
21. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136
22. Smaldone GC, Messina MS. Enhancement of particle deposition by flow-limiting segments in humans. J Appl Physiol 1985; 59:509-514
23. Carrard CS, Gerrity TR, Schreiner JF, et al. Analysis of aerosol deposition in the healthy human lung. Arch Environ Health 1981; 36:184-193
24. Diot P, Palmer LB, Smaldone GC, et al. RhDNase I aerosol deposition and related factors in cystic fibrosis. Am J Respir Crit Care Med 1997; 156:1662-1668
25. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999; 340:23-30
26. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meets ATS recommendations. Am Rev Respir Dis 1981; 123:659-664